Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Scott Streilein"'
Autor:
Danica Wasney, Vi Dao, Emily Rimmer, Scott Streilein, Leonard Minuk, Rami Kotb, Marc Geirnaert, Kristen Martin, Jacy Howarth, Chad Ricard
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:907-910
Background Daratumumab is used in the treatment of relapsed multiple myeloma. Daratumumab infusion-related reactions can occur with the highest incidence on the first infusion. Methods A retrospective review of all daratumumab infusions used as part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b574d9c680cbb28d9d245332480500ef
https://doi.org/10.1177/1078155220967738
https://doi.org/10.1177/1078155220967738
Autor:
Jacy Howarth, Scott Streilein, Chad Ricard, Kristen Martin, Marc Geirnaert, Saroj Niraula, Danica Wasney, Curtis Kellett
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:1683-1685
The product monograph for reference bevacizumab (Avastin) and biosimilar bevacizumab (Mvasi) recommend to infuse the first dose of bevacizumab over 90 min, second dose over 60 min and third and subsequent doses over 30 min. Despite the product monogr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8958ac36d6b3d5ab4eb664aa29293549
https://doi.org/10.1177/1078155220945374
https://doi.org/10.1177/1078155220945374
Autor:
Joseph Baptiste, James B. Johnston, Rajat Kumar, Sri Navaratnam, Bernie Lozar, Venetia Bourrier, Pamela Skrabek, Scott Streilein
Publikováno v:
Blood. 120:4701-4701
Abstract 4701 Introduction: In Manitoba (MB), population 1.25 million, utilization of parenteral oncology drugs is captured through a provincial oncology drug program (PODP) database. The MB Oncology Drug Utility and Clinical Outcomes Program (MODUCO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::641b1fbd9d96881e618de267d0d1b4b4
https://doi.org/10.1182/blood.v120.21.4701.4701
https://doi.org/10.1182/blood.v120.21.4701.4701